Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India.

Gogia, Ajay; Nair, Sukesh; Arora, Shalabh; Kumar, Lalit; Sharma, Atul; Gupta, Ritu; Biswas, Ahitagni; Mallick, Saumyaranjan

Gogia, Ajay; Nair, Sukesh; Arora, Shalabh; Kumar, Lalit; Sharma, Atul; Gupta, Ritu; Biswas, Ahitagni; Mallick, Saumyaranjan.

Afiliación

Gogia A; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
Nair S; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
Arora S; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
Kumar L; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
Sharma A; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
Gupta R; Department of Laboratory Oncology, All India Institute of Medical Sciences, New Delhi, India.
Biswas A; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India.
Mallick S; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.

Front Oncol ; 11: 770747, 2021.

Article en En | MEDLINE | ID: mdl-34926277

Palabras clave

CHOP (R-CHOP); India; cell of origin; diffuse large B-cell lymphoma (DLBCL); rituximab; survival

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google